- Home
- PGHL vs ADCT Comparison
PGHL vs ADCT Comparison
Compare PGHL & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGHL
- ADCT
- Stock Information
- Founded
- PGHL 2018
- ADCT 2011
- Country
- PGHL Hong Kong
- ADCT Switzerland
- Employees
- PGHL N/A
- ADCT N/A
- Industry
- PGHL
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- PGHL
- ADCT Health Care
- Exchange
- PGHL NYSE
- ADCT Nasdaq
- Market Cap
- PGHL 294.2M
- ADCT 285.2M
- IPO Year
- PGHL 2024
- ADCT 2020
- Fundamental
- Price
- PGHL $2.38
- ADCT $2.42
- Analyst Decision
- PGHL
- ADCT Strong Buy
- Analyst Count
- PGHL 0
- ADCT 5
- Target Price
- PGHL N/A
- ADCT $7.33
- AVG Volume (30 Days)
- PGHL 4.4M
- ADCT 458.4K
- Earning Date
- PGHL 12-10-2024
- ADCT 11-07-2024
- Dividend Yield
- PGHL N/A
- ADCT N/A
- EPS Growth
- PGHL N/A
- ADCT N/A
- EPS
- PGHL 0.05
- ADCT N/A
- Revenue
- PGHL $13,464,430.00
- ADCT $70,717,000.00
- Revenue This Year
- PGHL N/A
- ADCT $6.38
- Revenue Next Year
- PGHL N/A
- ADCT $11.73
- P/E Ratio
- PGHL $49.07
- ADCT N/A
- Revenue Growth
- PGHL 20.83
- ADCT N/A
- 52 Week Low
- PGHL $1.34
- ADCT $0.86
- 52 Week High
- PGHL $107.36
- ADCT $6.04
- Technical
- Relative Strength Index (RSI)
- PGHL N/A
- ADCT 45.56
- Support Level
- PGHL N/A
- ADCT $1.91
- Resistance Level
- PGHL N/A
- ADCT $2.38
- Average True Range (ATR)
- PGHL 0.00
- ADCT 0.23
- MACD
- PGHL 0.00
- ADCT -0.01
- Stochastic Oscillator
- PGHL 0.00
- ADCT 46.67
About PGHL PRIMEGA GROUP HOLDINGS LIMITED
Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.